Claim Missing Document
Check
Articles

Found 2 Documents
Search

Laporan Kasus: Hepatitis B pada Ibu Hamil yang Terdeteksi Melalui Triple Elimination Screening di Fasilitas Pelayanan Primer Susi Elvina Sari; Cut Khairunnisa
Inovasi Kesehatan Global Vol. 2 No. 4 (2025): November: Inovasi Kesehatan Global
Publisher : Lembaga Pengembangan Kinerja Dosen

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62383/ikg.v2i4.2339

Abstract

A 37-year-old woman, G3P2A0, at 16 weeks of gestation, came to the community health center for her first antenatal check-up. The patient had no characteristic clinical symptoms, but the triple elimination screening results showed reactivity for HBsAg, with negative HIV and syphilis results. An ultrasound examination revealed a viable intrauterine fetus with normal findings. The patient had not received Hepatitis B immunization or vitamin supplements previously, and the patient's partner had not undergone Hepatitis B screening despite having a work-related risk factor. The patient was given iron and vitamin supplements and referred to the hospital for further evaluation. Comprehensive education was provided regarding modes of transmission, risks of maternal and fetal infection, prevention of vertical transmission, as well as the importance of Hepatitis B immunization and the administration of HBIG to the newborn within 12 hours after birth. This case emphasizes the importance of early antenatal screening, comprehensive education, psychosocial support, and collaboration between the patient, family, and healthcare providers to prevent vertical transmission of Hepatitis B. The education provided included essential preventive measures and infection control steps to protect both the mother and the baby. Proper management and follow-up monitoring are necessary to ensure the health of the mother and baby and prevent further complications.
Profile of Chemotherapy Response with Platinum Based and Anthracycline Based on Breast Cancer Patients Susi Elvina Sari; Rizka, Adi; Iskandar, Iskandar
Jurnal Ilmiah Manusia Dan Kesehatan Vol. 8 No. 3 (2025): Jurnal Ilmiah MANUSIA DAN KESEHATAN
Publisher : FAKULTAS ILMU KESEHATAN UNIVERSITAS MUHAMMADIYAH PAREPARE

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31850/makes.v8i3.3973

Abstract

Breast cancer is the abnormal growth and development of cells in breast tissue. Chemotherapy is one of choice for treatment of breast cancer. Chemotherapy response was performed to predict survival rates in patients and can be a guideline for the next chemotherapy. The selection of chemotherapy regimen that is suitable for the patient’s condition must be considered so that the body can respond properly. Reduction in tumor size (objective response) is an important target evaluation of chemotherapy response. The purpose of this research is to determine the chemotherapy response profile in breast cancer patients undergoing chemotherapy at Cut Meutia Regional General Hospital. This study method used cross sectional method which was carried out in November 2022. Number of samples is 45 respondents which using purposive sampling technique who met the inclusion and exclusion criteria. The results of this study showed that the most age was >50 years old as many as 24 patients (53,3%), and The most gender was obtained, namely women as many as 45 patients (100%). Based on stage obtained for stage I amounted to 3 patients (6.7%), stage II amounted to 7 patients (15,6%), stage III amounted to 14 patients (31,1%), and for stage IV amounted to 21 patients (37,8%). Based on the type of chemotherapy that used platinum based in 17 patients (37.8%) and anthracycline based in 28 patients (62.2%). This study showed that there were 45 breast cancer patients at cut meutia general hospital with the majority reaching stage IV of 21 patients and the most used type of chemotherapy drug was anthracycline based as many as 28 patients.